If it spikes over $10 I am reducing my holding by 50%. I like the company a lot, but I have too much money in it given the challenges it (and the sector) faces.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%